StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.14+0.04 (+0.17%)

Close on Nov 18, 2026Market cap $463.06MP/E –Yield –

Neurogene market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Neurogene's market cap was $397.35M on Nov 11, 2026, against $311.46M a year earlier. Over the last 5 years it ranged from $86.72M to $1.24B, with a median of $311.46M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$397.35M+30.5%
2025Dec 31, 2025$304.37M+2.3%
2024Dec 31, 2024$297.43M+74.3%
2023Dec 29, 2023$170.65M+96.8%
2022Dec 30, 2022$86.72M-89.4%
2021Dec 31, 2021$818.01M-65.4%
2020Dec 31, 2020$2.36B+70.3%
2019Dec 31, 2019$1.39B+581.9%
2018Dec 31, 2018$203.36M-81.6%
2017Dec 29, 2017$1.10B-28.6%
2016Dec 30, 2016$1.55B+80.0%
2015Dec 31, 2015$859.22M+361.6%
2014Dec 31, 2014$186.15M–

More Neurogene figures

See a number that looks wrong?